Extrinsic factors derived from mouse embryonal carcinoma cell lines maintain pluripotency of mouse embryonic stem cells through a novel signal pathway

Embryonic carcinoma (EC) cells, which are malignant stem cells of teratocarcinoma, have numerous morphological and biochemical properties in common with pluripotent stem cells such as embryonic stem (ES) cells. However, three EC cell lines (F9, P19 and PCC3) show different developmental potential and self‐renewal capacity from those of ES cells. All three EC cell lines maintain self‐renewal capacity in serum containing medium without Leukemia Inhibitory factor (LIF) or feeder layer, and show limited differentiation capacity into restricted lineage and cell types. To reveal the underlying mechanism of these characteristics, we took the approach of characterizing extrinsic factors derived from EC cells on the self‐renewal capacity and pluripotency of mouse ES cells. Here we demonstrate that EC cell lines F9 and P19 produce factor(s) maintaining the undifferentiated state of mouse ES cells via an unidentified signal pathway, while P19 and PCC3 cells produce self‐renewal factors of ES cells other than LIF that were able to activate the STAT3 signal; however, inhibition of STAT3 activation with Janus kinase inhibitor shows only partial impairment on the maintenance of the undifferentiated state of ES cells. Thus, these factors present in EC cells‐derived conditioned medium may be responsible for the self‐renewal capacity of EC and ES cells independently of LIF signaling.

[1]  S. Shin,et al.  Suppression of PTEN expression during aggregation with retinoic acid in P19 mouse embryonal carcinoma cells. , 2006, Biochemical and biophysical research communications.

[2]  M. Okabe,et al.  Activation of Akt signaling is sufficient to maintain pluripotency in mouse and primate embryonic stem cells , 2006, Oncogene.

[3]  H. Niwa,et al.  Synergistic action of Wnt and LIF in maintaining pluripotency of mouse ES cells. , 2006, Biochemical and biophysical research communications.

[4]  J. Bastien,et al.  The phosphoinositide 3-kinase/Akt pathway is essential for the retinoic acid-induced differentiation of F9 cells , 2006, Oncogene.

[5]  Robert Lanza,et al.  Embryonic and extraembryonic stem cell lines derived from single mouse blastomeres , 2006, Nature.

[6]  L. Chin,et al.  Nuclear cloning of embryonal carcinoma cells. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[7]  Austin G Smith,et al.  Self-renewal of teratocarcinoma and embryonic stem cells , 2004, Oncogene.

[8]  N. Nakatsuji,et al.  STAT3 Is Dispensable for Maintenance of Self‐Renewal in Nonhuman Primate Embryonic Stem Cells , 2004, Stem cells.

[9]  Ana D. Lopez,et al.  Maintenance of Pluripotency in Human Embryonic Stem Cells Is STAT3 Independent , 2004, Stem cells.

[10]  P. Heinrich,et al.  Principles of interleukin (IL)-6-type cytokine signalling and its regulation. , 2003, The Biochemical journal.

[11]  M. Murakami,et al.  The Homeoprotein Nanog Is Required for Maintenance of Pluripotency in Mouse Epiblast and ES Cells , 2003, Cell.

[12]  J. Nichols,et al.  Functional Expression Cloning of Nanog, a Pluripotency Sustaining Factor in Embryonic Stem Cells , 2003, Cell.

[13]  K. Mizuseki,et al.  Induction of Midbrain Dopaminergic Neurons from ES Cells by Stromal Cell–Derived Inducing Activity , 2000, Neuron.

[14]  M. Katsuki,et al.  STAT3 activation is sufficient to maintain an undifferentiated state of mouse embryonic stem cells , 1999, The EMBO journal.

[15]  J. Nichols,et al.  Paracrine induction of stem cell renewal by LIF-deficient cells: a new ES cell regulatory pathway. , 1998, Developmental biology.

[16]  A. Smith,et al.  Self-renewal of pluripotent embryonic stem cells is mediated via activation of STAT3. , 1998, Genes & development.

[17]  T. Yamamoto,et al.  Alternative signaling mechanism of leukemia inhibitory factor responsiveness in a differentiating embryonal carcinoma cell. , 1997, Endocrinology.

[18]  Austin G Smith,et al.  Essential function of LIF receptor in motor neurons , 1995, Nature.

[19]  C. Stewart,et al.  Blastocyst implantation depends on maternal expression of leukaemia inhibitory factor , 1992, Nature.

[20]  L. Gudas,et al.  Specific expression of a retinoic acid-regulated, zinc-finger gene, Rex-1, in preimplantation embryos, trophoblast and spermatocytes. , 1991, Development.

[21]  John K. Heath,et al.  Inhibition of pluripotential embryonic stem cell differentiation by purified polypeptides , 1988, Nature.

[22]  Donald Metcalf,et al.  Myeloid leukaemia inhibitory factor maintains the developmental potential of embryonic stem cells , 1988, Nature.

[23]  J. Rossant,et al.  The developmental potential of a euploid male teratocarcinoma cell line after blastocyst injection. , 1982, Journal of embryology and experimental morphology.

[24]  M. McBurney,et al.  Isolation of male embryonal carcinoma cells and their chromosome replication patterns. , 1982, Developmental biology.

[25]  G. Martin,et al.  Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[26]  M. Kaufman,et al.  Establishment in culture of pluripotential cells from mouse embryos , 1981, Nature.

[27]  A. Levine,et al.  Alterations in the developmental potential of embryonal carcinoma cells in mixed aggregates of nullipotent and pluripotent cells , 1979, Cell.

[28]  D. Solter,et al.  Monoclonal antibody defining a stage-specific mouse embryonic antigen (SSEA-1). , 1978, Proceedings of the National Academy of Sciences of the United States of America.

[29]  B. Ephrussi,et al.  Alkaline phosphatase activity in mouse teratoma. , 1973, Proceedings of the National Academy of Sciences of the United States of America.

[30]  I. Klimanskaya,et al.  Human embryonic stem cell lines derived from single blastomeres , 2006, Nature.

[31]  P. Greengard,et al.  Maintenance of pluripotency in human and mouse embryonic stem cells through activation of Wnt signaling by a pharmacological GSK-3-specific inhibitor , 2004, Nature Medicine.

[32]  D. Hilton,et al.  Inhibition of differentiation in a murine F9 embryonal carcinoma cell subline by leukemia inhibitory factor (LIF). , 1992, Growth factors.

[33]  J. D. Engel,et al.  Developmental potential. , 1992, Genes & development.